Novel Stem Cell Therapy Repairs Irreversible Corneal Damage in Clinical Trial
On Mar. 4, 2025, researchers at a Mass Eye and Ear Institute-led trial announced taking stem cells from…
On Mar. 4, 2025, researchers at a Mass Eye and Ear Institute-led trial announced taking stem cells from…
On Mar. 4, 2025, the Government of Alberta announced it had contributed $100 million in capital funding to…
On Mar. 4, 2025, the Texas Department of State Health Services reported an outbreak of measles in the…
On Mar. 3, 2025, the Institute for Health Metrics and Evaluation reported that without urgent policy reform and…
On Mar. 3, 2025, researchers from Oregon State University (OSU) announced the world’s first procedure successfully fixes lamb’s…
On Mar. 3, 2025, Revvity announced the launch of EUROIMMUN’s CE-marked Anti-Measles Virus ELISA 2.0 (IgG) to support…
On Mar. 3, 2025, epidemiologists at the Texas A&M University School of Public Health have identified a link…
On Mar. 3, 2025, researchers at Fred Hutch Cancer Center announced they have discovered an overlooked mechanism driving…
On Feb. 28, 2025, the World Health Organization (WHO) announced announced the recommendations for the viral composition of…
On Feb. 27, 2025, the U.S. Centers for Disease Control and Prevention (CDC) announced that it is investigating…
On Feb. 27, 2025, a new government report adds to evidence that the HPV vaccine, once called dangerous…
On Feb. 27, 2025, ALK announced that the U.S. Food and Drug Administration (FDA) has approved ALK’s ODACTRA®…
On Feb. 27, 2025, research from Oregon State University (OSU) showed that wild birds can account for much…
On Feb. 26, 2025, the U.S. Department of Agriculture (USDA0 announced a $1 billion-dollar comprehensive strategy to curb…
On Feb. 26, 2025, the Texas Department of State Health Services reported the first death from measles in…
In Feb. 26, 2025, Eli Lilly announced that it plans to bolster its domestic medicine production across therapeutic…
On Feb. 24, 2025, the Texas Department of State Health Services reported an outbreak of measles in centered…
On Feb. 24, 2025, breast cancer is the most common cancer in women worldwide, but survival chances vary…
On Feb. 21, 2025, Novo Nordisk announced that the U.S. Food and Drug Administration (FDA) has determined the…
On Feb. 21, 2025, a team of researchers from the Marine Biological Laboratory (MBL) announced a hybrid custom-designed…
On Feb. 20, 2025, researchers from the University of Washington and Seattle Children’s Research Institute announced findings from…
On Feb. 19, 2025, the Cancer Prevention and Research Institute of Texas (CPRIT) announced that it had approved…
On Feb. 19, 2025, Alcon announced the full U.S. commercial availability of Voyager™ DSLT, the first and only…
On Feb. 19, 2025, research from the Texas A&M College of Veterinary Medicine and Biomedical Sciences has discovered…
On Feb. 19, 2025, scientists at St. Jude Children’s Research Hospital report results from a promising new approach…
On Feb. 18, 2025, a research expedition led by Antonio Alcamí at the Severo Ochoa Molecular Biology Center…
On Feb. 18, 2025, Hologic announced that the U.S. Food and Drug Administration (FDA) has granted 510(k) clearance…
On Feb. 18, 2025, scientists from the Institute for Systems Biology announced they have developed a breakthrough method…
On Feb. 17, 2025, Stanford researchers have conducted the first large-scale screen of these inherited changes, called single…
On Feb. 14, 2025, the World Health Organization (WHO) announced that a cumulative of two confirmed and eight…